Boai NKY Pharmaceuticals Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.79%

Boai NKY Pharmaceuticals Ltd (300109) has an Asset Resilience Ratio of 0.79% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Boai NKY Pharmaceuticals Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥33.59 Million
≈ $4.92 Million USD Cash + Short-term Investments

Total Assets

CN¥4.24 Billion
≈ $620.82 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Boai NKY Pharmaceuticals Ltd's Asset Resilience Ratio has changed over time. See Boai NKY Pharmaceuticals Ltd (300109) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Boai NKY Pharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300109 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥33.59 Million 0.79%
Total Liquid Assets CN¥33.59 Million 0.79%

Asset Resilience Insights

  • Limited Liquidity: Boai NKY Pharmaceuticals Ltd maintains only 0.79% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Boai NKY Pharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Boai NKY Pharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
Specialty Chemicals 2.16%
Air Products and Chemicals Inc
NYSE:APD
Specialty Chemicals 2.49%
Akzo Nobel NV
AS:AKZA
Specialty Chemicals 2.16%
Swancor Advanced Materials Co Ltd
SHG:688585
Specialty Chemicals 11.19%
Azelis Group NV
BR:AZE
Specialty Chemicals 0.00%
Shenzhen Rongda Photosensitive & Technology Co Ltd
SHE:300576
Specialty Chemicals 9.08%
Jihua Group Corp Ltd
SHG:601718
Specialty Chemicals 0.00%
Jiangxi Guotai Civilian
SHG:603977
Specialty Chemicals 12.39%

Annual Asset Resilience Ratio for Boai NKY Pharmaceuticals Ltd (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Boai NKY Pharmaceuticals Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.71% CN¥30.98 Million
≈ $4.53 Million
CN¥4.37 Billion
≈ $639.77 Million
-0.14pp
2023-12-31 0.85% CN¥34.20 Million
≈ $5.00 Million
CN¥4.02 Billion
≈ $588.21 Million
-0.01pp
2022-12-31 0.86% CN¥31.99 Million
≈ $4.68 Million
CN¥3.71 Billion
≈ $543.41 Million
-4.19pp
2021-12-31 5.06% CN¥201.71 Million
≈ $29.52 Million
CN¥3.99 Billion
≈ $583.85 Million
+3.97pp
2020-12-31 1.09% CN¥45.03 Million
≈ $6.59 Million
CN¥4.15 Billion
≈ $606.61 Million
+2.72pp
2019-12-31 -1.63% CN¥-68.37 Million
≈ $-10.00 Million
CN¥4.20 Billion
≈ $614.11 Million
-1.22pp
2018-12-31 -0.41% CN¥-9.48 Million
≈ $-1.39 Million
CN¥2.30 Billion
≈ $337.02 Million
-0.32pp
2017-12-31 -0.09% CN¥-1.83 Million
≈ $-268.20K
CN¥1.96 Billion
≈ $286.61 Million
-3.22pp
2016-12-31 3.13% CN¥41.00 Million
≈ $6.00 Million
CN¥1.31 Billion
≈ $191.68 Million
+3.19pp
2015-12-31 -0.06% CN¥-725.33K
≈ $-106.14K
CN¥1.24 Billion
≈ $180.86 Million
--
2010-12-31 0.00% CN¥0.00
≈ $0.00
CN¥357.81 Million
≈ $52.36 Million
--
pp = percentage points

About Boai NKY Pharmaceuticals Ltd

SHE:300109 China Specialty Chemicals
Market Cap
$1.34 Billion
CN¥9.15 Billion CNY
Market Cap Rank
#7853 Global
#1953 in China
Share Price
CN¥18.92
Change (1 day)
-0.05%
52-Week Range
CN¥15.65 - CN¥20.47
All Time High
CN¥149.39
About

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, or… Read more